Elanco Animal Health (NASDAQ:ELAN) – Equities researchers at Gabelli issued their FY2023 earnings estimates for Elanco Animal Health in a research report issued to clients and investors on Thursday, February 7th. Gabelli analyst K. Kedra forecasts that the company will earn $1.95 per share for the year.

Other equities research analysts have also recently issued reports about the stock. BMO Capital Markets decreased their price objective on shares of Elanco Animal Health from $32.00 to $1.13 and set a “market perform” rating for the company in a research report on Wednesday, December 19th. They noted that the move was a valuation call. Credit Suisse Group reiterated a “hold” rating and set a $33.00 price objective on shares of Elanco Animal Health in a research report on Friday, January 4th. JPMorgan Chase & Co. assumed coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They set an “overweight” rating and a $38.00 price objective for the company. Cowen assumed coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They set an “outperform” rating for the company. Finally, Citigroup assumed coverage on shares of Elanco Animal Health in a research report on Monday, October 15th. They set a “buy” rating and a $37.00 price objective for the company. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and six have assigned a buy rating to the stock. Elanco Animal Health currently has a consensus rating of “Hold” and a consensus price target of $31.10.

ELAN opened at $29.69 on Friday. Elanco Animal Health has a twelve month low of $28.00 and a twelve month high of $37.61.

Elanco Animal Health (NASDAQ:ELAN) last posted its quarterly earnings data on Wednesday, February 6th. The company reported $0.29 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.26 by $0.03. The firm had revenue of $799.30 million for the quarter, compared to analyst estimates of $804.07 million. During the same quarter last year, the company earned $0.12 earnings per share. The company’s quarterly revenue was up 6.0% compared to the same quarter last year.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Focused Wealth Management Inc bought a new position in Elanco Animal Health during the fourth quarter worth $32,000. First Hawaiian Bank bought a new position in Elanco Animal Health during the fourth quarter worth $35,000. Public Employees Retirement Association of Colorado bought a new position in Elanco Animal Health during the fourth quarter worth $83,000. Oppenheimer Asset Management Inc. bought a new position in Elanco Animal Health during the fourth quarter worth $214,000. Finally, Tower Research Capital LLC TRC bought a new position in Elanco Animal Health during the third quarter worth $224,000.

About Elanco Animal Health

There is no company description available for Elanco Animal Health Inc

Read More: Asset Allocation and Your Retirement

Receive News & Ratings for Elanco Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elanco Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.